Vertex Pharmaceuticals Incorporated
VRTX
$436.60
-$0.42-0.10%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.50% | 2.93% | 1.39% | -6.26% | 12.58% |
| Total Receivables | 2.79% | 4.90% | 12.16% | -8.07% | 5.71% |
| Inventory | 8.50% | 10.27% | 12.80% | 11.63% | 18.06% |
| Prepaid Expenses | 8.53% | 10.02% | 26.66% | 4.67% | -16.99% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 20.16% | -79.74% | -70.36% | 1,866.67% | -77.61% |
| Total Current Assets | 1.36% | 4.19% | 4.30% | -2.12% | 9.65% |
|
|
|||||
| Total Current Assets | 1.36% | 4.19% | 4.30% | -2.12% | 9.65% |
| Net Property, Plant & Equipment | 13.89% | 0.55% | 1.93% | 2.81% | 41.97% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -1.31% | -1.29% | -46.58% | -0.69% | -0.70% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.17% | 6.80% | 6.78% | 1.26% | 6.93% |
| Total Assets | 3.43% | 5.05% | 1.54% | 1.32% | 10.47% |
|
|
|||||
| Total Accounts Payable | -4.97% | -0.61% | 7.75% | 4.35% | 20.71% |
| Total Accrued Expenses | 10.48% | 10.80% | 12.34% | -18.39% | 9.51% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 29.63% | -- |
| Total Finance Division Other Current Liabilities | 3.78% | 10.09% | -10.51% | 50.77% | 2.54% |
| Total Other Current Liabilities | 3.78% | 10.09% | -10.51% | 50.77% | 2.54% |
| Total Current Liabilities | 8.14% | 9.39% | 6.13% | -10.28% | 12.01% |
|
|
|||||
| Total Current Liabilities | 8.14% | 9.39% | 6.13% | -10.28% | 12.01% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 20.13% | -7.38% | -0.49% | -2.68% | 82.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.17% | 25.59% | 5.56% | -3.38% | 6.44% |
| Total Liabilities | 9.94% | 7.47% | 4.26% | -7.35% | 23.37% |
|
|
|||||
| Common Stock & APIC | -16.29% | -2.99% | -7.49% | -3.38% | -2.75% |
| Retained Earnings | 9.60% | 10.07% | 6.73% | 10.50% | 13.67% |
| Treasury Stock & Other | 36.20% | -248.46% | -46.71% | 343.75% | 28.00% |
| Total Common Equity | 0.83% | 4.12% | 0.53% | 4.98% | 5.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 0.83% | 4.12% | 0.53% | 4.98% | 5.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 0.83% | 4.12% | 0.53% | 4.98% | 5.80% |
|
|
|||||